Alzheimer’s - Providence Business News

Home Tags Alzheimer’s

Five Questions With: Isaac Stoner

Health Services 12/07/2025

Isaac Stoner is the newly appointed CEO of MindImmune Therapeutics, a University of Rhode Island spinout company working to develop novel treatments for Alzheimer’s...

BOLDEN Therapeutics Inc., a Rhode Island biotech company and Brown University spinoff founded by Dr. Justin Fallon, pictured, received $1.5 million in pre-seed funding to advance its research in treating Alzheimer’s. / COURTESY BROWN UNIVERSITY

R.I. biotech company secures $1.5M in funding for Alzheimer’s research

Economic Activity 01/23/2024

PROVIDENCE – A Rhode Island-based biotech company received $1.5 million in pre-seed funding to advance its research in treating Alzheimer’s disease. The financing, led by...

BOLD Infrastructure for Alzheimer’s Act OKs $100M for public health response

Government 01/07/2019

WASHINGTON, D.C. — The $100 million Building Our Largest Dementia, or BOLD, Infrastructure for Alzheimer’s Act, recently signed into law, applies a public health...

- Featured Event -

Latest News

SUBSCRIBE TO

PBN's All Access Subscription

PBN subscribers get ahead with unlimited access to PBN news, information, and insights from our editorial team, research and data, webinars and much more.